ArticleCurrent cancer drug targets2025

WEE Family Kinase Inhibitors Combined with Sorafenib Can Selectively Inhibit HCC Cell Proliferation.

Anling Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.